Apostolos Papavasileiou
- Drug resistance pattern of mycobacterium tuberculosis complex at the main reference tuberculosis centre in Greece, 2000-2010By Panagiotis Zois, Pinelopi Sotiropoulou, Apostolos Papavasileiou, Konstantina Broupi, Stavroula Katsaflia, Simona Karabela, Konstantinos Gourgoulianis and Konstantinos KonstantinouPanagiotis Zois112th Department of Pneumonology, Sotiria Chest Diseases Hospital, Athens, GreecePinelopi Sotiropoulou4Health Visiting Department, Higher Technological Educational Institute, Athens, GreeceApostolos Papavasileiou2Anti-Tuberculosis Department, Sotiria Chest Diseases Hospital, Athens, GreeceKonstantina Broupi2Anti-Tuberculosis Department, Sotiria Chest Diseases Hospital, Athens, GreeceStavroula Katsaflia2Anti-Tuberculosis Department, Sotiria Chest Diseases Hospital, Athens, GreeceSimona Karabela5National Reference Laboratory for Mycobacteria, Sotiria Chest Diseases Hospital, Athens, GreeceKonstantinos Gourgoulianis3Department of Pneumonology, School of Medicine, University of Thessaly, Larissa, GreeceKonstantinos Konstantinou2Anti-Tuberculosis Department, Sotiria Chest Diseases Hospital, Athens, Greece
- Knowledge and attitude about tuberculosis disease in a health workers populationBy Stamatoula Tsikrika, Apostolos Papavasileiou, Dimitris Papaventsis, Panagiotis Ioannidis and Kostantinos KostantinouStamatoula Tsikrika1TB Unit, 'Sotiria' Chest Diseases Hospital, 'Sotiria' Chest Diseases Hospital, Athens, GreeceApostolos Papavasileiou1TB Unit, 'Sotiria' Chest Diseases Hospital, 'Sotiria' Chest Diseases Hospital, Athens, GreeceDimitris Papaventsis1TB Unit, 'Sotiria' Chest Diseases Hospital, 'Sotiria' Chest Diseases Hospital, Athens, GreecePanagiotis Ioannidis1TB Unit, 'Sotiria' Chest Diseases Hospital, 'Sotiria' Chest Diseases Hospital, Athens, GreeceKostantinos Kostantinou1TB Unit, 'Sotiria' Chest Diseases Hospital, 'Sotiria' Chest Diseases Hospital, Athens, Greece
- The performance of flow cytometry in the diagnosis of latent tuberculosis infection in patients under treatment with anti-TNFa and other biological agentsBy Chrysovalantis Papageorgiou, Maria Ploussi, Simona Karabela, Kyriakos Fotiadis, Andreas Anastasopoulos, Apostolos Papavasileiou, Evangelos Vogiatzakis, Dimitrios Ioakeimidis, Angelos Gritzapis and Nikolaos PoulakisChrysovalantis Papageorgiou1Dept. of Pulmonary Medicine, Locus Medicus S.A., Athens, GreeceMaria Ploussi2Laboratory of Cellular Biology and Immunology, Locus Medicus S.A., Athens, GreeceSimona Karabela3Microbiology Dept., National Reference Laboratory for Mycobacteria, Sotiria Hospital of Chest Diseases, Athens, GreeceKyriakos Fotiadis4Rheumatology Dept., General Hospital of Athens ‘G. Gennimatas', Athens, GreeceAndreas Anastasopoulos51st dept. of Pulmonary Medicine, Sotiria Hospital of Chest Diseases, Athens, GreeceApostolos Papavasileiou6Clinic for Multidrug-Resistant Tuberculosis, Sotiria Hospital of Chest Diseases, Athens, GreeceEvangelos Vogiatzakis3Microbiology Dept., National Reference Laboratory for Mycobacteria, Sotiria Hospital of Chest Diseases, Athens, GreeceDimitrios Ioakeimidis4Rheumatology Dept., General Hospital of Athens ‘G. Gennimatas', Athens, GreeceAngelos Gritzapis2Laboratory of Cellular Biology and Immunology, Locus Medicus S.A., Athens, GreeceNikolaos Poulakis1Dept. of Pulmonary Medicine, Locus Medicus S.A., Athens, Greece
- Characteristics of patients under treatment for NTM disease during the period 2004-2013 in GreeceBy Katerina Manika, Stamatoula Tsikrika, Emilia Tsaroucha, Ioannis Kioumis and Apostolos PapavasileiouKaterina Manika1Respiratory Infections Unit, Pulmonary Department, Aristotle University of Thessaloniki, "G. Papanikolaou" Hospital, Thessaloniki, GreeceStamatoula Tsikrika2MDR/XDR TB Unit, "Sotiria" Chest Diseases Hospital, Athens, Athens, GreeceEmilia Tsaroucha2MDR/XDR TB Unit, "Sotiria" Chest Diseases Hospital, Athens, Athens, GreeceIoannis Kioumis1Respiratory Infections Unit, Pulmonary Department, Aristotle University of Thessaloniki, "G. Papanikolaou" Hospital, Thessaloniki, GreeceApostolos Papavasileiou2MDR/XDR TB Unit, "Sotiria" Chest Diseases Hospital, Athens, Athens, Greece
- Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, Lia D'Ambrosio, Valentina Alarcon Guizado, Jan Willem Alffenaar, Marcos Abdo Arbex, Jose A. Caminero, Rosella Centis, Saverio De Lorenzo, Mina Gaga, Gina Gualano, Aurora Jazmín Roby Arias, Anna Scardigli, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Onno W. Akkerman, Edith Alarcon Arrascue, Alena Aleska, Vera Avchinko, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriArticle | Published in 2016 in European Respiratory JournalSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workMarie-Christine Payen2Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium30These authors contributed equally to this workGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy5Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workValentina Alarcon Guizado6National Tuberculosis Control Programme, Ministry of Health, Lima, PeruJan Willem Alffenaar7Dept of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsMarcos Abdo Arbex8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilJose A. Caminero10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, Spain11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalySaverio De Lorenzo12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyMina Gaga13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAurora Jazmín Roby Arias15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceAlena Skrahina16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic17National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, SlovakiaGiorgia Sulis18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini19Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyOnno W. Akkerman20Dept of Pulmonary Diseases and Tuberculosis, TB Center Beatrixoord, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsEdith Alarcon Arrascue11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France21International Union Against Tuberculosis and Lung Disease (The Union), Lima, PeruAlena Aleska22Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Avchinko16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries23KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst24Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, Lia D'Ambrosio, Valentina Alarcon Guizado, Jan Willem Alffenaar, Marcos Abdo Arbex, Jose A. Caminero, Rosella Centis, Saverio De Lorenzo, Mina Gaga, Gina Gualano, Aurora Jazmín Roby Arias, Anna Scardigli, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Onno W. Akkerman, Edith Alarcon Arrascue, Alena Aleska, Vera Avchinko, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workMarie-Christine Payen2Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium30These authors contributed equally to this workGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy5Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workValentina Alarcon Guizado6National Tuberculosis Control Programme, Ministry of Health, Lima, PeruJan Willem Alffenaar7Dept of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsMarcos Abdo Arbex8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilJose A. Caminero10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, Spain11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalySaverio De Lorenzo12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyMina Gaga13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAurora Jazmín Roby Arias15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceAlena Skrahina16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic17National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, SlovakiaGiorgia Sulis18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini19Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyOnno W. Akkerman20Dept of Pulmonary Diseases and Tuberculosis, TB Center Beatrixoord, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsEdith Alarcon Arrascue11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France21International Union Against Tuberculosis and Lung Disease (The Union), Lima, PeruAlena Aleska22Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Avchinko16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries23KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst24Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Marcos Abdo Arbex, Edith Alarcon Arrascue, Jan Willem Alffenaar, Jose A. Caminero, Mina Gaga, Gina Gualano, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Valentina Alarcon Guizado, Saverio De Lorenzo, Aurora Jazmín Roby Arias, Anna Scardigli, Onno W. Akkerman, Alena Aleksa, Janina Artsukevich, Vera Auchynka, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Marie-Christine Payen, Andrea Piana, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriArticle | Published in 2016 in European Respiratory JournalSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workGiovanni Sotgiu2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy4Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workRosella Centis3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy30These authors contributed equally to this workMarcos Abdo Arbex5University Center of Araraquara, Sao Paulo, Brazil6Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilEdith Alarcon Arrascue7International Union against Tuberculosis and Lung Disease (The Union), Lima, Peru8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, FranceJan Willem Alffenaar9University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The NetherlandsJose A. Caminero8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, SpainMina Gaga11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano12Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAlena Skrahina13Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic14National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, SlovakiaGiorgia Sulis15University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini16Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyValentina Alarcon Guizado17National Tuberculosis Control Programme, Ministry of Health, Lima, PeruSaverio De Lorenzo18AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyAurora Jazmín Roby Arias19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, FranceOnno W. Akkerman20University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis; TB Center Beatrixoord, Groningen, The NetherlandsAlena Aleksa21Educational Institution “Grodno State Medical University”, Grodno, BelarusJanina Artsukevich21Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Auchynka13Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini5University Center of Araraquara, Sao Paulo, Brazil6Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries22KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst23Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli15University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri12Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceMarie-Christine Payen24Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, BelgiumAndrea Piana2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani18AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
